Veterinary Medicines

HIPRADOG-7, Injekce

Authorised
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Penn 103/70, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
Download as PDF

Product identification

Medicine name:
HIPRADOG-7, Injekce
Active substance:
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Penn 103/70, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain Lederle, Live
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
Target species:
  • Dog (puppy)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, strain Cornell 780916, Live
    7.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Penn 103/70, Live
    6.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    7.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain Lederle, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, Inactivated
    1000000000.00
    Protective Dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
    1000000000.00
    Protective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/048/03-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download